RazFit vs ZoeMD
Side-by-side comparison to help you choose the right product.
ZoeMD
ZoeMD is your AI clinical assistant, delivering instant, evidence-based medical answers to enhance healthcare decisions.
Last updated: March 1, 2026
Visual Comparison
RazFit

ZoeMD

Overview
About RazFit
RazFit is a native iOS fitness app built 100% in SwiftUI for iPhone and iPad. It delivers high-intensity bodyweight workouts in just 1 to 10 minutes a day — no gym or equipment required. The app features AI coaching with two virtual trainers, Orion and Lyss, who evaluate your fitness level and adapt exercises automatically. A gamification system with 32 unlockable milestones keeps you motivated through an entire year of training. Every exercise includes easier and harder modifications so you control your progression. RazFit is designed for all fitness levels, from complete beginners to advanced athletes. It leverages iOS 18+ technologies for a fast, smooth native experience. Start with a 3-day free trial.
About ZoeMD
ZoeMD is an innovative, evidence-based medical AI assistant that revolutionizes the way healthcare professionals access and utilize medical knowledge. This cutting-edge platform is designed specifically for physicians, medical students, and researchers, empowering them to obtain fast and reliable answers at the point of care. By providing immediate access to clinical guidelines, key studies, and best-practice recommendations, ZoeMD enhances the decision-making process, allowing clinicians to focus more on patient care. The main value proposition of ZoeMD lies in its ability to streamline clinical workflows, significantly reducing the time spent searching for information. It enhances confidence in clinical judgment without replacing it, acting as a trusted partner in navigating the complexities of evidence-based medicine. ZoeMD is dedicated to ensuring that healthcare professionals have the most relevant and up-to-date information at their fingertips, ultimately improving patient outcomes and the overall quality of care.